# Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

> **NCT00002831** · PHASE1,PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 24 (actual)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** Filgrastim
- **DRUG:** Busulfan
- **DRUG:** Cyclophosphamide
- **DRUG:** Cyclosporine
- **DRUG:** Decitabine (DAC)
- **DRUG:** Methotrexate
- **DRUG:** Methylprednisolone
- **DRUG:** Tacrolimus
- **PROCEDURE:** Allogeneic Bone Marrow Transplantation
- **PROCEDURE:** Peripheral Blood Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00002831
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-08-01
- **Primary completion:** 2002-12-31
- **Final completion:** 2002-12-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002831, "Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00002831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*